ITP
LUNG icon

Iron Triangle Partners’s Pulmonx LUNG Stock Holding History

Iron Triangle Partners’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-550,000
Closed -$24.3M – 29
2021
Q2 		$24.3M Sell
550,000
-50,000
-8% -$2.18M 2.5% 20
2021
Q1 		$27.4M Buy
+600,000
New +$34.4M 3.49% 14

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Iron Triangle Partners's LUNG Position: Q3 2021 in Review

Iron Triangle Partners sold out of Pulmonx (LUNG) in Q3 2021, closing a stake of 550,000 shares — an estimated $24.3M sold.

Iron Triangle Partners first reported a position in LUNG in Q1 2021 and held it in 2 quarters. The position peaked at $27.4M in Q1 2021. 120 funds tracked by Wall St. Rank hold LUNG as of Q3 2021.

  • Iron Triangle Partners reported no remaining Pulmonx position as of Q3 2021 after selling out during the quarter.
  • Iron Triangle Partners sold 550,000 Pulmonx shares in Q3 2021, an estimated $24.3M.
  • Iron Triangle Partners first reported a position in Pulmonx in Q1 2021 and held it in 2 quarters.
  • Iron Triangle Partners's Pulmonx position peaked at $27.4M in Q1 2021.
  • 120 funds tracked by Wall St. Rank held Pulmonx as of Q3 2021.

Based on Iron Triangle Partners's 13F filing for Q3 2021, filed 15 Nov 2021.